Engineered precancerous cells and tissues for discovery of lung cancer drivers
Description: PUBLIC HEALTH RELEVANCE Small cell lung cancer is the most aggressive form of lung cancers that affects both men and women and cause deaths of approximately 30,000 patients in the United States and 200,000 patients worldwide each year. We propose to discover key molecular determinants of the cancer progression and test functional significance of frequently mutated genes in human tumors. The outcome of the proposal will provide crucial information to be used to develop novel strategies to prevent and treat the lung cancer patients.
Funder: National Cancer Institute
Funding type: research
Funder scheme: R03
Start date: 2017-08-01
End date: 2020-07-31
Investigator: KWON-SIK PARK (lead)
Institution: University of Virginia
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Funded outputs count: 5
Funder award ID: R03CA215777
OpenAlex ID: G7991043363
